Clinical Trials Sponsored by NeuroRx, Inc.

Total 35618 results

NeuroRx, Inc.

Recruiting

Inhaled ZYESAMI™ (Aviptadil Acetate) for the Treatment of Severe COVID-19 (AVICOVID-2)

SARS-CoV 2 | COVID | ARDS | Acute Lung Injury/Acute Respiratory Distress Syndrome (ARDS) | Dyspnea | ALI

United States
NeuroRx, Inc.

Not yet recruiting

NRX-101 for Complicated Urinary Tract Infection (UTI) Including Pyelonephritis

Urinary Tract Infections | Pyelonephritis
NeuroRx, Inc.
Target Health Inc.

Completed

NRX101 Glx Biomarker Validation Study (NRX-GLX)

Suicidal Ideation | Bipolar Depression

United States
NeuroRx, Inc.
Prevail Infoworks, Inc

Completed

NRX-101 for Bipolar Depression With Subacute Suicidal Ideation

Bipolar Depression | Suicidal Ideation and Behavior

United States
NeuroRx, Inc.
Target Health Inc.

Active, not recruiting

NRX-101 for Maintenance of Remission From Severe Bipolar Depression in Patients With Suicidal Ideation (SBD-ASIB)

Suicidal Ideation | Bipolar Depression

United States
NeuroRx, Inc.
Target Health Inc.

Active, not recruiting

NRX100 vs. Placebo for Rapid Stabilization of Acute Suicidal Ideation and Behavior in Bipolar Depression (SevereBD)

Suicidal Ideation | Bipolar Depression

United States
NeuroRx, Inc.
Prevail Infoworks

Available

NRX-101 Expanded Access (NRX-101EAP)

Bipolar Depression | Bipolar Affective Disorder
Neurop Inc.

Completed

Safety and Pharmacokinetics of NP10679 in Normal Healthy Volunteers

Safety Issues

United States
Neumora Therapeutics, Inc.

Recruiting

Study to Evaluate the Effects of Oral NMRA 335140 Versus Placebo in Participants With Major Depressive Disorder

Major Depressive Disorder

United States
NeuroBo Pharmaceuticals Inc.

Completed

A Single and Multiple Ascending Dose Study of Niclosamide in Healthy Volunteers

Healthy

United States
NeuroBo Pharmaceuticals Inc.

Completed

Study of Niclosamide in Moderate and Severe Hospitalized Coronavirus-19 (COVID-19) Patients

COVID-19

United States
NeuroBo Pharmaceuticals Inc.

Completed

A 12-Week Study to Assess the Efficacy Safety and Tolerability of Gemcabene in Subjects With Severe Hypertriglyceridemia (INDIGO-1)

Severe Hypertriglyceridemia | Mixed Dyslipidaemia

United States, Canada
NeuroBo Pharmaceuticals Inc.

Completed

Effect of Gemcabene on the Pharmacokinetics of Simvastatin in Healthy Volunteers

Hypercholesterolemia
Neumora Therapeutics, Inc.

Recruiting

Study to Assess the Effects of Oral NMRA-335140 Versus Placebo in Participants With Major Depressive Disorder

Major Depressive Disorder

United States
NeuroBo Pharmaceuticals Inc.

Recruiting

Study to Evaluate the Efficacy and Safety of DA-1241 in Subjects With Presumed NASH

NON-ALCOHOLIC STEATOHEPATITIS

United States
NeuroPro Therapeutics, Inc.

Completed

Safety and Pharmacokinetic Study of NPT 2042 Soft-gelatin Capsules Administered Orally to Healthy Adult Subjects

Epilepsy | Alzheimer Disease | Epilepsy Intractable

United States
NeuroBo Pharmaceuticals Inc.

Completed

A 12-Week, Phase 2 Study of Gemcabene in Hypercholesterolemia Patients on Stable Moderate and High-Intensity Statins (ROYAL-1)

Hypercholesteremia

United States
NeuroBo Pharmaceuticals Inc.

Completed

Effect of Gemcabene on the Pharmacokinetics of Atorvastatin in Healthy Volunteers

Hypercholesteremia
NeuroRx, Inc.
Massachusetts General Hospital; Target Health Inc.

Completed

Sequential Therapy for the Treatment of Severe Bipolar Depression. (STABIL-B)

Suicidal Ideation | Suicide, Attempted | Bipolar Depression | Suicidal Ideas

United States
NeuroBo Pharmaceuticals Inc.

Recruiting

First in Human Study in Subjects With Obesity, But Otherwise Healthy

Obesity

United States
Neumora Therapeutics, Inc.

Recruiting

Study to Assess the Effects of Oral NMRA-335140 in Participants With Major Depressive Disorder

Major Depressive Disorder

United States
Neumora Therapeutics, Inc.

Recruiting

Study to Assess the Safety and Effectiveness of NMRA-335140-501

Major Depressive Disorder

United States
NeuroBo Pharmaceuticals Inc.

Completed

Efficacy and Safety of Gemcabene in Patients With Homozygous Familial Hypercholesterolemia on Stable, Lipid-Lowering Therapy (COBALT-1)

Hypercholesteremia

United States, Canada, Israel
NeuroBo Pharmaceuticals Inc.

Completed

Efficacy and Safety of Gemcabene in Patients With Low HDL-C and Either Normal or Elevated Triglycerides

Hypercholesterolemia | Hypertriglyceridemia
NeuroBo Pharmaceuticals Inc.

Completed

Efficacy and Safety of Gemcabene in Hypercholesterolemic Patients as Monotherapy or in Combination With Atorvastatin

Hypercholesterolemia
NeuroBo Pharmaceuticals Inc.

Completed

The Effect of Gemcabene on Insulin Sensitivity in Nondiabetic Subjects

Insulin Sensitivity
NeuroBo Pharmaceuticals Inc.

Completed

Pharmacokinetics and Pharmacodynamics Study of Gemcabene in Healthy Volunteers

Hypercholesterolemia
NeuroBo Pharmaceuticals Inc.

Completed

Efficacy and Safety of Gemcabene in Hypercholesterolemic Patients on Stable Statin Therapy

Hypercholesterolemia
Neuros Medical, Inc.

Active, not recruiting

Electrical Nerve Block for Amputation Pain

Phantom Limb Pain | Residual Limb Pain | Post-Amputation Pain | Stump Pain

United States
NeuMoDx Molecular, Inc.
NAMSA

Completed

NeuMoDx PrEDiCTiNG Study Evaluation Plan

Neisseria Gonorrheae Infection | Chlamydia Trachomatis Infection

United States
BlackThorn Therapeutics, Inc.
Neumora Therapeutics, Inc.

Completed

Study in Major Depressive Disorder With BTRX-335140 (NMRA-335140) vs Placebo

Major Depressive Disorder

United States
NeuroDx Development

Withdrawn

Multi-Center Study of ShuntCheck

Blocked Ventricular Shunts
Alzamend Neuro, Inc.

Completed

Multiple Ascending Dose Safety, Tolerability, PK Study of AL001 in Alzheimer's Disease Patients & Healthy Adult Subjects ("MAD")

Alzheimer's Disease | Healthy Non-elderly and Elderly Adults

United States, Canada
Spark Neuro Inc.

Recruiting

SPARK Neuro REMIND Study

Cognitive Impairment | Alzheimer Disease

United States
Clionsky Neuro Systems Inc.

Completed

COMPARATIVE EFFECTIVENESS OF MCI and DEMENTIA TREATMENTS IN A COMMUNITY-BASED DEMENTIA PRACTICE

Brain Injuries | Hypoxia | Parkinson's Disease | Anemia | TDP-43 Proteinopathies | Dementia | Tauopathies | Mild Cognitive Impairment | Iron Deficiency | Vitamin B 12 Deficiency | Frontotemporal Dementia | Vascular Dementia | Alzheimer's Disease | Neurodegenerative Disorders | TBI | Lewy Body Dementia | Hyperhomocysteinemia
Neuro Event Labs Inc.

Recruiting

A Study of Detection of Paroxysmal Events Utilizing Computer Vision and Machine Learning - Nelli

Epilepsy

United States
Neuro Event Labs Inc.

Completed

A Study of Detection of Paroxysmal Events Utilizing Computer Vision and Machine Learning

Epilepsy

United States
Clionsky Neuro Systems Inc.

Completed

Concussion in Motor Vehicle Accidents: The Concussion Identification Index (CIDI)

Brain Injuries | TBI (Traumatic Brain Injury) | Motor Vehicle Accidents | Brain Concussion | Brain Contusion | Traumatic Brain Injury With Brief Loss of Consciousness | Cerebral Concussion | Accidents, Traffic | Traumatic Brain Injury With Loss of Consciousness | Traffic Accidents | Cortical Contusion | Concussion... and other conditions

United States
Neuronyx

Completed

Safety Study of Bone Marrow Derived Cells to Treat Damaged Heart Muscle

Myocardial Infarction

United States
NeuroRx, Inc.
Cromos; Brilife Georgia; Israel Institute for Biological Research

Withdrawn

Phase 2b/3 Trial of VSV-ΔG SARS-CoV-2 Vaccine (BRILIFE) Against Approved Comparator Vaccine. (BRILIFE002)

COVID-19
Pamlab, Inc.
Clionsky Neuro Systems Inc.

Unknown

A Retrospective Analysis of Cerefolin NAC® in Cognitively Impaired Patients

Mild Cognitive Impairment

United States
Alzamend Neuro, Inc.
bioRASI, LLC

Active, not recruiting

Study in Subjects With Mild-to-Moderate Alzheimer's Dementia

Alzheimer Disease

United States
Mayo Clinic
Spark Neuro Inc.

Enrolling by invitation

Development of an EEG Diagnostic for Alzheimer's Disease

Alzheimer Disease | Mild Cognitive Impairment | Dementia With Lewy Bodies | Normal Control APOE e4 Carriers and Noncarriers

United States
Mayo Clinic
Spark Neuro Inc.

Completed

EEG Diagnostic for Repetitive Sub-concussive Head Impacts

Concussion

United States
Fujirebio Diagnostics, Inc.
Medical Research Networx LLC

Terminated

A Prospective Longitudinal Collection of Subjects Diagnosed With Small Cell Lung Cancer

Small Cell Lung Cancer

United States
Neuronix Ltd

Terminated

Effects of a NeuroAD System, for the Treatment of Alzheimer Disease

Alzheimer's Disease

Israel
Neurofix S.L.

Completed

Clinical Trial to Evaluate Safety, Tolerability and Efficacy of NFX88 in SCI

Neuropathic Pain | Spinal Cord Injuries

Spain
Neuronix Ltd

Completed

Effect of NeuroAD on the Cognitive Function of Alzheimer Patients

Alzheimer's Disease

United States, Israel
Eisai Inc.
Symphony Neuro Development Company

Completed

2 Year Study to Evaluate the Effects of GPI 1485 on [123I]b-CIT/SPECTScanning and Clinical Efficacy in Patients With PD

Parkinson's Disease
Eisai Inc.
Symphony Neuro Development Company

Completed

Evaluate the Effects of GPI 1485 on Erectile Function Following Bilateral Nerve-Sparing Prostatectomy

Prostate Cancer | Impotence

United States

Clinical Trials Sponsored by NeuroRx, Inc.

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Iran

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations